BioDelivery Sciences International Inc. (BDSI)

4.43
0.02 0.45
NASDAQ : Health Technology
Prev Close 4.45
Open 4.43
Day Low/High 4.39 / 4.50
52 Wk Low/High 2.55 / 5.37
Volume 325.32K
Avg Volume 937.10K
Exchange NASDAQ
Shares Outstanding 89.52M
Market Cap 395.69M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

NEW YORK, July 29, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of BioDelivery...

3 Small-Caps That Look Like Bargains at Current Trading Levels

3 Small-Caps That Look Like Bargains at Current Trading Levels

The trio consists of BioDelivery Sciences International, Beazer Homes USA and Redhill Biopharma.

BioDelivery Sciences Announces Further Improved Insurance Coverage For BELBUCA®

BioDelivery Sciences Announces Further Improved Insurance Coverage For BELBUCA®

Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.

These Two Small-Cap Stocks Are Executing Well

These Two Small-Cap Stocks Are Executing Well

Both Digital Turbine and BioDelivery Sciences have done well in 2019.

BioDelivery Sciences International Is Now Oversold (BDSI)

BioDelivery Sciences International Is Now Oversold (BDSI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

I am incrementally using buy-write option orders to add some shares to core holdings.

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

Lifshitz & Miller LLP Announces Investigation Of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., And Care.com, Inc.

Lifshitz & Miller LLP Announces Investigation Of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., And Care.com, Inc.

NEW YORK, March 22, 2019 /PRNewswire/ -- Alta Mesa Resources, Inc. (AMR) Lifshitz & Miller announces investigation into possible securities laws violations in connection with AMR identifying "ineffective internal control over financial reporting.

Interesting BDSI Put And Call Options For May 17th

Interesting BDSI Put And Call Options For May 17th

Investors in BioDelivery Sciences International Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BDSI options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

My Post-Earnings Assessment of 2 Biotech Stocks

My Post-Earnings Assessment of 2 Biotech Stocks

Let's look at a couple of companies we have covered on these pages before.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Breaches Of Fiduciary Duty By BioDelivery Sciences International, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Breaches Of Fiduciary Duty By BioDelivery Sciences International, Inc.

Levi & Korsinsky announces it has commenced an investigation of BioDelivery Sciences International, Inc.

TheStreet Quant Rating: D (Sell)